Hiroya Tamai

9PUBLICATIONS
28CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Clinical social work practiceSport and exercise nutritionMedical biochemistry - proteins and peptides (incl. medical proteomics)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 05, 2026
Association of genetic variants with extravascular complications and cytokine production in Takayasu arteritis: a cross-sectional study.

Farzana Shumy, Kotaro Matsumoto, Masaru Takeshita

|Apr 01, 2025
Achievement and Usefulness of Intermediate Treatment Targets for Still Disease Proposed by the European Alliance of Associations for Rheumatology and the Paediatric Rheumatology European Society.

Hiroya Tamai, Sora Ito, Satoshi Takanashi

|Mar 18, 2025
1 mg/day or 10 mg/week? Folic acid supplementation with methotrexate in rheumatoid arthritis.

Hiroya Tamai, Tsutomu Takeuchi, Yuko Kaneko

|Oct 04, 2024
Association of methotrexate polyglutamates concentration with methotrexate efficacy and safety in patients with rheumatoid arthritis treated with predefined dose: results from the MIRACLE trial.

Hiroya Tamai, Kei Ikeda, Toshiaki Miyamoto

|Mar 26, 2024
Effects of interleukin-6 signal inhibition on Treg subpopulations and association of Tregs with clinical outcomes in rheumatoid arthritis.

Hiroto Yoshida, Mayu Magi, Hiroya Tamai

|Mar 20, 2024
Tocilizumab discontinuation after remission achievement in patients with adult-onset Still's disease.

Hiroya Tamai, Yasushi Kondo, Tsutomu Takeuchi

Pageof 2

Frequent Collaborators

3 joint publications

Yuko Kaneko

2 joint publications

Tsutomu Takeuchi

2 joint publications

Shintaro Hirata

2 joint publications

Hiroto Yoshida